Correlation Between Pmv Pharmaceuticals and Relmada Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Relmada Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Relmada Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pmv Pharmaceuticals and Relmada Therapeutics, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Relmada Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Relmada Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Relmada Therapeutics.
Diversification Opportunities for Pmv Pharmaceuticals and Relmada Therapeutics
-0.19 | Correlation Coefficient |
Good diversification
The 3 months correlation between Pmv and Relmada is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Relmada Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Relmada Therapeutics and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Relmada Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Relmada Therapeutics has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Relmada Therapeutics go up and down completely randomly.
Pair Corralation between Pmv Pharmaceuticals and Relmada Therapeutics
Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to under-perform the Relmada Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Pmv Pharmaceuticals is 2.0 times less risky than Relmada Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The Relmada Therapeutics is currently generating about 0.33 of returns per unit of risk over similar time horizon. If you would invest 66.00 in Relmada Therapeutics on August 17, 2025 and sell it today you would earn a total of 329.00 from holding Relmada Therapeutics or generate 498.48% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pmv Pharmaceuticals vs. Relmada Therapeutics
Performance |
| Timeline |
| Pmv Pharmaceuticals |
| Relmada Therapeutics |
Pmv Pharmaceuticals and Relmada Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pmv Pharmaceuticals and Relmada Therapeutics
The main advantage of trading using opposite Pmv Pharmaceuticals and Relmada Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Relmada Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relmada Therapeutics will offset losses from the drop in Relmada Therapeutics' long position.| Pmv Pharmaceuticals vs. Immunic | Pmv Pharmaceuticals vs. Relmada Therapeutics | Pmv Pharmaceuticals vs. Acrivon Therapeutics, Common | Pmv Pharmaceuticals vs. Vaxart Inc |
| Relmada Therapeutics vs. Acrivon Therapeutics, Common | Relmada Therapeutics vs. Pmv Pharmaceuticals | Relmada Therapeutics vs. Immunic | Relmada Therapeutics vs. Tscan Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |